Lyell Immunopharma, Inc. (LYEL) Earnings
Lyell Immunopharma, Inc. is expected to report next earnings on August 11, 2026 (in NaN days), with a consensus EPS estimate of $-2.03. LYEL has beaten EPS estimates in 9 of its last 12 reported quarters (average surprise -40.1% over the last four).
Next earnings
Aug 11, 2026in NaN days
EPS est $-2.03 · Revenue est $5750
Track record
Beat EPS in 9 of 12 quarters
Avg surprise -40.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 6, 2026 | $-2.78 | $-1.10 | +60.4% | $2000 | -33.3% |
| Mar 12, 2026 | $-2.23 | $-8.23 | -268.9% | $6000 | -70.5% |
| Nov 12, 2025 | $-2.81 | $-2.13 | +24.2% | $15000 | — |
| Aug 12, 2025 | $-3.80 | $-2.89 | +23.9% | $8000 | +100.0% |
| Mar 11, 2025 | $-0.18 | $-0.72 | -300.0% | $11000 | — |
| Nov 7, 2024 | $-0.20 | $-0.17 | +15.0% | $34000 | — |
| Feb 28, 2024 | $-0.21 | $-0.20 | +4.8% | $13000 | +300.0% |
| May 4, 2023 | $-0.28 | $-0.27 | +3.6% | $65000 | +471.4% |
| Feb 28, 2023 | $-0.31 | $-0.03 | +90.3% | $48386 | -99.7% |
| Aug 4, 2022 | $-0.31 | $-0.15 | +51.6% | $36M | +100.0% |
| Nov 12, 2021 | $-0.27 | $-0.20 | +25.9% | $3M | -20.6% |
| Aug 12, 2021 | $-0.36 | $-0.89 | -147.2% | $3M | +0.0% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.